1 / 10

Brent Bankosky - BS, Microbiology From Penn State University

Brent Charles Bankosky's expansiveness of experience traverses different enterprises, for example, synthetic concoctions, pharmaceuticals, and medical devices. Brent applies innovation, creativity and a keen business sense that he has developed during his career to enable companies to reach their potential. To know more about him visit his official site https://brentbankosky.com

brentbankosky
Download Presentation

Brent Bankosky - BS, Microbiology From Penn State University

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Brent Bankosky C h i e f O p e ra t i n g O f f i c e r a t E nv i ro Te c h C h e m i c a l S e r v i c e s

  2. Brent Bankosky has been a business executive with sales, marketing, R&D, regulatory and manufacturing experience in several highly regulated industries.

  3. Currently, Brent Charles Bankosky oversees sales and operations at Enviro Tech, no.1 in generating new sales, set pricing for over 200 products to over 300 distributors in the US, negotiate and sign corporate agreements, prepare and submit corporate sales proposals and manage the operating performance of Enviro Tech.

  4. Prior to this, Brent Bankosky serves as a Vice President (Business Development) officer at Tranzyme Pharma, Durham, NC in 2011-2012.

  5. As a VP Brent Charles Bankosky was responsible for leading corporate business development for the company reporting to the President& CEO.

  6. Responsible for licensing partnership discussions involving Tranzyme’s advanced drug candidates, ulimorelin, in Ph3 for improving GI recovery following surgery, and TZP-102, in Ph2b for diabetic gastroparesis. Ulimorelin and TZP-102 did not meet clinical endpoints in clinical trials. The company was sold.

  7. Managed a partnership with Bristol-Myers Squibb involving Tranzyme’s macrocylic template chemistry platform (MATCH™) targeted at CNS, Immunology, and GI therapeutic area disease targets.

  8. Besides all this, Brent Charles Bankosky also is active with many charitable organizations, including Habitat for Community, the American Diabetes Association and the Juvenile Diabetes Research Foundation (JDRF). Brent is a member of various industry organizations.

  9. THANK YOU Find out more about him at his official site https://brentbankosky.com Read More

More Related